Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gw Pharma ADR (NQ: GWPH )

151.72 USD +1.49 (+0.99%)
Streaming Delayed Price Updated: 9:53 AM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Gw Pharma ADR

< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
GW Pharmaceuticals plc Reports Second Quarter 2014 Financial Results and Operational Progress
Conference Call Today at 8:00 a.m. ET, 1:00 p.m. BST 
From GlobeNewswire News Releases
GW Pharmaceuticals Receives Investigational New Drug (IND) From FDA for Phase 2/3 Clinical Trial of Epidiolex(R) in the Treatment of Dravet Syndrome
From GlobeNewswire News Releases
GW Pharmaceuticals Appoints Dr. Kenneth Sommerville as VP, Clinical Science
Position Created to Support U.S. Medical Affairs and Regulatory Activities Related to Epilepsy Programs 
From GlobeNewswire News Releases
Earnings Results, Acquisitions, Drug Designations, Dividend Authorizations, and Licensing Agreements - Analyst Notes on AstraZeneca, Furiex, GW, Techne and Agenus
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
GW Pharmaceuticals to Report Q2 2014 and Half Year Financial Results and Host Conference Call on 7 May, 2014
From GlobeNewswire News Releases
NTRR Prepares to Bring New Products Online
From Business Wire News Releases
GW Pharmaceuticals Announces That Sativex Receives Fast Track Designation From FDA in Cancer Pain
From GlobeNewswire News Releases
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
NTRR Continues Distribution Talks at Cannabis Cup
From Business Wire News Releases
NTRR Opens Distribution Talks
From Business Wire News Releases
Early Briefing on Pharma Equities -- Research on TherapeuticsMD, Pacira Pharma, GW Pharma, and Depomed
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
NTRR to Showcase New Vapor Pen at Cannabis Cup
From Business Wire News Releases
Marijuana Index Fights Through Recent Pressure - Company Looks To Reduce Outstanding Shares To Fund Expansion
From PR Newswire
Medical Marijuana Operators and Facility Providers Expand Operations - Company Adds Well Known, Major Marijuana Authority to Board of Directors
From PR Newswire
Marijuana Sector Turns Green with High Volume Activity - Company Strengthens Security Platform With Highly Experienced CTO In Cyber Security Industry
From PR Newswire
NTRR Readies New Asset for Distribution Network
From Business Wire News Releases
Cannabis Sector Continues Rapid Expansions - Company Locates Headquarters in California & Announces 506 Capital Raise Initiative
From PR Newswire
FDA Approvals, Financial Highlights, Restated Treatment Indications, and Updates on Product Pipelines - Analyst Notes on Bristol-Myers Squibb, Galena, Teleflex, GW Pharmaceuticals, and CytRx
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
NTRR: Cannabis Market Growth Poised to Outpace Smartphones
From Business Wire News Releases
Medical Marijuana Industry Hitting New Highs -Company Closes $4.6 Million Dollar Acquisition of 83,000 S/F Industrial Park
From PR Newswire
GW Pharmaceuticals Provides Update on Cannabinoid Pipeline
From GlobeNewswire News Releases
New Drug Applications, Earnings Release Schedules, Drug Designations, New Services, and Clinical Trials - Analyst Notes on Actavis, Intercept, GW Pharmaceuticals, Galena, and Conatus
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Cannabis Market Continues Rapid Growth: Advancer with Recent Acquisitions Moves Forward to Become Full Reporting Company
From PR Newswire
GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex(R) in the Treatment of Lennox-Gastaut Syndrome
From GlobeNewswire News Releases
GW Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference
From GlobeNewswire News Releases
Cannabis Sector's High Volume Trading Report - Company Enters Into Agreement with a Colorado Marijuana Facility Developer
From PR Newswire
$PTOG News: Cannabis Sector Briefing: Company Launches Natural Resource Development Program for Marijuana & Hemp Products
Tags cannabis PTOG OTC: PTOG
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Cannabis Sector Briefing: Company Launches Natural Resource Development Program for Marijuana & Hemp Products
From PR Newswire
Medical Marijuana Explosion Continues as Company Agrees to Purchase 83,000 S/F Complex in AZ
From PR Newswire
GW Pharmaceuticals to Present at the Leerink Global Healthcare Conference
From GlobeNewswire News Releases
< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.